Biophysical Methods
New Strategies and Technologies for Precision Characterization of Complex Biologics
5/11/2027 - May 12, 2027 ALL TIMES EDT
As biologic pipelines diversify, the need for precise, high-throughput, and predictive characterization tools has never been greater. The Biophysical Methods conference brings together innovators advancing automation, miniaturization, and multi-modal analytics to address the unique challenges of today's complex therapeutic proteins. Topics range from microfluidic assay development and robotic sample handling to in-silico modeling of aggregation, viscosity, and self-association risks. Presentations will spotlight cutting-edge mass spectrometry, imaging, and AI-powered analysis for everything from computationally designed binders to nanobodies and co-formulations. By blending experimental data with modeling frameworks, this program highlights practical solutions for linking biophysical properties to potency, immunogenicity, and clinical performance—helping researchers de-risk development and accelerate promising candidates toward the clinic.
Preliminary Agenda

PLENARY KEYNOTE SESSION

Panel Moderator:

PANEL DISCUSSION: From Mechanism to Modality: Smarter Drug Design in Autoimmunity

Yang Shen, PhD, Executive Director, Antibody Engineering, Bispecifics, Regeneron , Vice President , Bispecifics & Antibody Engineering , Regeneron

Panelists:

Stephen J. Demarest, PhD, CSO, Tentarix Biotherapeutics , CSO , Tentarix

Ryan P. Larson, PhD, Vice President & Head, Translational Sciences, Umoja Biopharma , SVP & Head , Translational Sciences , Umoja Biopharma

Kira Rubtsova, PhD, Associate Vice President, Eli Lilly and Company , Dir , Eli Lilly & Co

Qizhi Tang, PhD, Professor in Residence, Surgery, University of California San Francisco , Prof in Residence , Surgery , Univ of California San Francisco

IN SILICO PREDICTION OF VISCOSITY AND SELF-ASSOCIATION

Predicting Antibody Viscosity across Concentration Scales Using Simplified Models and Dilute-Solution Properties

Photo of Robin Curtis, PhD, Senior Lecturer, University of Manchester , Sr Lecturer , University of Manchester
Robin Curtis, PhD, Senior Lecturer, University of Manchester , Sr Lecturer , University of Manchester

Beyond Conventional mAbs: Predicting Self-Association and Viscosity in High-Concentration Antibody Solutions with Molecular Simulation and AI

Photo of Pin-Kuang Lai, PhD, Assistant Professor, Chemical Engineering and Materials Science, Stevens Institute of Technology , Dr , Chemical Engineering and Materials Science , Stevens Institute of Technology
Pin-Kuang Lai, PhD, Assistant Professor, Chemical Engineering and Materials Science, Stevens Institute of Technology , Dr , Chemical Engineering and Materials Science , Stevens Institute of Technology

Viscosity models trained on conventional mAbs often struggle to generalize to multispecific antibodies. In collaboration with Janssen, we developed a coarse-grained model that represents antibodies as combinations of shared building blocks, including Fv, scFv, VHH, and Fc. Machine learning uses existing mAb data to estimate component parameters, enabling predictions of self-association and viscosity at high concentrations without additional multispecific training data. This approach supports candidate selection for subcutaneous antibody delivery.

PHYSICAL AND DIGITAL AUTOMATION IN BIOPHYSICAL ANALYSIS

Scaling Active Concentration Assays: Automation and High-Throughput Approaches to Stress-Induced Binding Loss

Photo of Tina Matin, PhD, Senior Scientist, Protein Engineering, Sanofi , Senior Scientist , Sanofi
Tina Matin, PhD, Senior Scientist, Protein Engineering, Sanofi , Senior Scientist , Sanofi
Photo of Megan Salemi, Scientist, Large Molecule Research, Sanofi , Scientist , Large Molecule Research , Sanofi Grp
Megan Salemi, Scientist, Large Molecule Research, Sanofi , Scientist , Large Molecule Research , Sanofi Grp

Early developability screening is often limited to few candidates. We present a high-throughput binding-stability assay on the Carterra LSA XT that measures active concentration after stress. Validated against Biacore, it enables profiling of ~70 candidates under multiple pH and timepoint conditions per run, supporting earlier, data-driven selection and reduced late-stage attrition.

An Integrated Automated Workflow for Unpaired Cysteine Characterization in ADC Lead Selection

Fan Zhang, PhD, Principal Scientist, Merck & Co. , Principal Scientist , Merck & Co.

As biologics pipelines continue to expand, scalable analytical workflows are essential for rapid candidate assessment. We present an automated high-throughput free thiol assay that enables rapid characterization of unpaired cysteines across diverse antibody formats. By integrating robotic sample preparation with streamlined data acquisition and analysis, the platform delivers improved throughput, reproducibility, and data quality. This approach enables faster identification of critical liabilities and supports data-driven candidate selection during discovery.

KEYNOTE PRESENTATION

KEYNOTE PRESENTATION: Nanoscale Molecular Cartography of the Cellular Membranes

Kallol Gupta, PhD, Associate Professor, Cell Biology, Yale School of Medicine , Associate Professor , Cell Biology , Yale School of Medicine

NEW TECHNOLOGIES FOR CHARACTERIZING HIGHER-ORDER STRUCTURE

Photo of Igor A. Kaltashov, PhD, Professor, Chemistry, University of Massachusetts, Amherst , Professor , Chemistry , Univ of Massachusetts Amherst
Igor A. Kaltashov, PhD, Professor, Chemistry, University of Massachusetts, Amherst , Professor , Chemistry , Univ of Massachusetts Amherst

Correlating Multiplex NMR Methods with Potency, Post-Translational Modifications, and Structural Perturbations of Monoclonal Antibodies

Photo of Mingyue Li, PhD, Principal Scientist, Pfizer Inc. , Principal Scientist , Pfizer Inc
Mingyue Li, PhD, Principal Scientist, Pfizer Inc. , Principal Scientist , Pfizer Inc

Assessing the structural integrity of therapeutic monoclonal antibodies is critical in drug development. We present an NMR-based approach linking stress-induced changes to biological activity. Three antibodies exposed to light and heat stress were analyzed by NMR, mass spectrometry and cell-based assays. NMR distinguished stress types and correlated with activity. We show that NMR offers a fast, non-destructive way to assess antibody integrity, connecting structural changes, chemical modifications and biological function.

NEW APPLICATIONS OF MS IN DEVELOPMENT

High-throughput LC and MS methods for Protein Engineering and Characterization

Photo of Robert T. Kennedy, PhD, Hobart H. Willard Distinguished Professor & Chair, Chemistry & Pharmacology, University of Michigan , Hobart H Willard Distinguished Prof & Chair , Chemistry & Pharmacology , Univ of Michigan
Robert T. Kennedy, PhD, Hobart H. Willard Distinguished Professor & Chair, Chemistry & Pharmacology, University of Michigan , Hobart H Willard Distinguished Prof & Chair , Chemistry & Pharmacology , Univ of Michigan

Liquid chromatography and mass spectrometry are essential tools for pharmaceutical development and protein engineering. However, the throughput of analysis is limiting in many cases. For example, enzyme engineering requires screening thousands of variants but using 1 min LC assays can result in excessive analysis times. Likewise, assays for characterizing protein based such as peptide mapping can require long times which can become burdensome when screening hundreds of drugs. We have developed high-throughput MS and LC methods so that such assays can be performed in the seconds range with potential for reducing to sub-second assays.

Mapping Cystine Knot Connectivity in a Therapeutic Protein Using Conventional LC-MS/MS and AI-Enabled Data Analysis

Photo of Leo Wang, PhD, Senior Scientist, Takeda , Sr. Scientist , Analytical Development - Pharmaceutical Sciences , Takeda
Leo Wang, PhD, Senior Scientist, Takeda , Sr. Scientist , Analytical Development - Pharmaceutical Sciences , Takeda

Cystine-knot regions challenge LC-MS/MS disulfide mapping. For a therapeutic protein, we resolved a three-peptide complex containing four disulfide bonds and a three-consecutive-cysteine (CCC) motif using two workflows on conventional LC-MS/MS. Controlled partial reduction with TCEP and NEM alkylation generated simpler intermediates for stepwise assignment. In parallel, direct HCD with optimized collision energies and fragments consolidated across injections resolved the connectivity without reduction. AI-assisted fragment prediction and spectral annotation supported analysis. Both workflows yielded the same disulfide map without ETD, offering practical routes from early- through late-stage development. Funding: this study was sponsored by Takeda Development Center Americas, Inc.

HDX-MS-Guided Computational Modeling for Rapid and Accurate Antibody-Antigen Interface Mapping

Photo of Hanzhi Zhang, PhD, Associate Principal Scientist, AstraZeneca , Associate Principal Scientist , AstraZeneca
Hanzhi Zhang, PhD, Associate Principal Scientist, AstraZeneca , Associate Principal Scientist , AstraZeneca

Accurate mapping of paratopes and epitopes at antibody-antigen (Ab-Ag) interfaces is essential for the rational design of therapeutic antibodies in early drug development. Traditional methods for determining high-resolution Ab-Ag complex structures are labor-intensive and require substantial time and resources. Here, we present a hydrogen-deuterium exchange mass spectrometry (HDX-MS)-guided structural modeling workflow for efficient and accurate epitope and paratope mapping across three prospective case studies in therapeutic protein discovery and engineering.

EMERGING BIOPHYSICAL METHODS

A Few Degrees of Separation: Making Sense of SPR Kinetics across Temperatures

Photo of Jon Barricelli, Senior Scientist, Biomolecular Interactions Group, AstraZeneca , Senior Scientist , Biomolecular Interactions Group , AstraZeneca
Jon Barricelli, Senior Scientist, Biomolecular Interactions Group, AstraZeneca , Senior Scientist , Biomolecular Interactions Group , AstraZeneca

Enhancing Temporal Resolution in Epitope Mapping via Millisecond HDX-MS: Beyond Conventional Timescales

Photo of Malvina Papanastasiou, PhD, Senior Group Leader & Research Scientist, Proteomics Platform, Broad Institute , Senior Group Leader & Research Scientist , Proteomics Platform , Broad Institute
Malvina Papanastasiou, PhD, Senior Group Leader & Research Scientist, Proteomics Platform, Broad Institute , Senior Group Leader & Research Scientist , Proteomics Platform , Broad Institute

Evaluating Antibody Quality via Single Protein Oscillators

Photo of Shaopeng Wang, PhD, Associate Professor, Biodesign Center for Bioelectronics & Biosensors, Arizona State University , Associate Prof , Biodesign Center for Bioelectronics & Biosensors , Arizona State Univ
Shaopeng Wang, PhD, Associate Professor, Biodesign Center for Bioelectronics & Biosensors, Arizona State University , Associate Prof , Biodesign Center for Bioelectronics & Biosensors , Arizona State Univ

Evaluating aggregation of therapeutic monoclonal antibodies is critical for quality assessment. We developed a label-free single-protein oscillator method to simultaneously measure the size and charge of monoclonal antibodies and differentiate aggregation levels at single-protein resolution. Single proteins tethered to a sensor surface via a flexible polymer were driven into oscillation by an alternating electric field and imaged through near-field optical imaging. Mapping the charge/size distribution of aggregates at single-particle resolution revealed heterogeneous charge distributions among aggregates of similar size, indicating structural changes in monomers and conformers that are not readily accessible with existing methods.


For more details on the conference, please contact:
Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: 207-329-2964
Email: [email protected]

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Email: [email protected]

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-1340
Email: [email protected]


Register

View By:


Premier Sponsors

Biointron_new       Kactus